chr12-132618863-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_170682.4(P2RX2):c.47G>T(p.Arg16Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000328 in 1,221,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 29)
Exomes 𝑓: 0.0000033 ( 0 hom. )
Consequence
P2RX2
NM_170682.4 missense
NM_170682.4 missense
Scores
2
3
14
Clinical Significance
Conservation
PhyloP100: 0.0210
Genes affected
P2RX2 (HGNC:15459): (purinergic receptor P2X 2) The product of this gene belongs to the family of purinoceptors for ATP. This receptor functions as a ligand-gated ion channel. Binding to ATP mediates synaptic transmission between neurons and from neurons to smooth muscle. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2487953).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
P2RX2 | NM_170682.4 | c.47G>T | p.Arg16Leu | missense_variant | 1/11 | ENST00000643471.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
P2RX2 | ENST00000643471.2 | c.47G>T | p.Arg16Leu | missense_variant | 1/11 | NM_170682.4 | A2 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD3 genomes
Cov.:
29
GnomAD3 exomes AF: 0.00000843 AC: 1AN: 118630Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67696
GnomAD3 exomes
AF:
AC:
1
AN:
118630
Hom.:
AF XY:
AC XY:
0
AN XY:
67696
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000328 AC: 4AN: 1221194Hom.: 0 Cov.: 31 AF XY: 0.00000333 AC XY: 2AN XY: 599748
GnomAD4 exome
AF:
AC:
4
AN:
1221194
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
599748
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 29
GnomAD4 genome
Cov.:
29
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Apr 08, 2022 | This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 16 of the P2RX2 protein (p.Arg16Leu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with P2RX2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.;.;.;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;D;T;T;D;T;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;M;M;M;M;M;.
MutationTaster
Benign
N;N;N;N;N;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;N;N;N;D;N;N;N;.
REVEL
Benign
Sift
Uncertain
.;D;D;D;D;D;D;D;.
Sift4G
Benign
.;T;T;T;D;T;D;T;T
Polyphen
P;P;D;D;P;D;P;P;P
Vest4
0.25, 0.32, 0.28, 0.20, 0.23, 0.24, 0.21, 0.28
MutPred
Loss of MoRF binding (P = 0.0186);Loss of MoRF binding (P = 0.0186);Loss of MoRF binding (P = 0.0186);Loss of MoRF binding (P = 0.0186);Loss of MoRF binding (P = 0.0186);Loss of MoRF binding (P = 0.0186);Loss of MoRF binding (P = 0.0186);Loss of MoRF binding (P = 0.0186);Loss of MoRF binding (P = 0.0186);
MVP
0.54
MPC
1.9
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at